학술논문

Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype
Document Type
Article
Source
In Annals of Oncology September 2020 31(9):1178-1185
Subject
Urogenital tumors
Language
ISSN
0923-7534